TreviPay Partners with BlueSnap to Integrate Trade Credit and Invoicing Card Processing Solutions for Global B2B Businesses

3 years ago

TreviPay and BlueSnap release industry-first global B2B payments solution that offers both trade credit and card payment processing with consolidated…

3 years ago

- Plans to enter the global foodservice market - Animated eating show with cartoon host and food, no risk of…

China Defense Industry Report 2022: Expenditure Expected to be $318.6 Billion by 2027 – Trends, Budget Allocation, Regulations, Key Acquisitions, Competitive Landscape and Forecasts – ResearchAndMarkets.com

3 years ago

DUBLIN--(BUSINESS WIRE)--The "China Defense Market Size and Trends, Budget Allocation, Regulations, Key Acquisitions, Competitive Landscape and Forecast, 2022-2027" report has…

The 4th Dahua Partner Day Held in Paris

3 years ago

HANGZHOU, China--(BUSINESS WIRE)--#AI--Dahua Technology, a world-leading video-centric smart IoT solution and service provider, hosted the 4th Dahua Partner Day at…

3 years ago

Tru Niagen� was recognized for its industry-leading research, increased presence on cross-border e-commerce channels, and high engagement on several social…

3 years ago

Tru Niagen� was recognized for its industry-leading research, increased presence on cross-border e-commerce channels, and high engagement on several social…

3 years ago

CHARLOTTE, N.C.--(BUSINESS WIRE)--$IPX #3Dprinting--IperionX Limited (�IperionX� or �Company�) (Nasdaq: IPX, ASX: IPX) is pleased to release the Company's inaugural Sustainability…

Quizartinib Granted Priority Review in the U.S. for Patients with Newly Diagnosed FLT3-ITD Positive Acute Myeloid Leukemia

3 years ago

Submission based on QuANTUM-First results showing quizartinib plus chemotherapy significantly improved overall survival compared to chemotherapy alone TOKYO & BASKING…

3 years ago

CHARLOTTE, N.C.--(BUSINESS WIRE)--$IPX #3Dprinting--IperionX Limited (�IperionX� or �Company�) (Nasdaq: IPX, ASX: IPX) is pleased to release the Company's inaugural Sustainability…

Quizartinib Granted Priority Review in the U.S. for Patients with Newly Diagnosed FLT3-ITD Positive Acute Myeloid Leukemia

3 years ago

Submission based on QuANTUM-First results showing quizartinib plus chemotherapy significantly improved overall survival compared to chemotherapy alone TOKYO & BASKING…

Show more Posts
Show previous Posts